KRAS and malignant colon neoplasm: Highlighting the complexity of miRNA networks, these findings demonstrate a reciprocal negative regulation between the oncomiR miR-21 and the tumor suppressor miR-145, modulated by KRAS signaling, which collectively governs CSC properties and chemoresistance in colon cancer.